Sort
82,697 grants matching “vaccine development”
Immunobiology, molecular virology and countermeasures of highly pathogenic viruses
$1,379,371Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
PREVENTION OF MATERNAL AND CONGENITAL CMV INFECTION
$1,378,590University Of Alabama At Birmingham · P01 · FY2001 · AI
UC Davis/NIH NeuroMab Facility
$1,378,565James S Trimmer · University Of California At Davis · U24 · FY2014 · NS
Project 2 - Development of HLA-E-peptide antibodies for enhancing NK and CD8 killing of HIV infected CD4 T cells in vivo
$1,378,444Mihai Luchian Azoitei · University Of Alabama At Birmingham · P01 · FY2025 · AI
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)
$1,378,282Jeanette Coffin · Midwest Research Institute · N01 · FY2018 · AI
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)
$1,377,991Peter D. Friedmann · Baystate Medical Center, Inc. · UH3 · FY2019 · DA
Pediatric AIDS Clinical Trials Unit
$1,377,953Children'S Memorial Hospital (Chicago) · U01 · FY2005 · AI
Project 3: Mechanistic studies and comparisons of vaccines in preclinical models
$1,377,304Bali Pulendran · University Of Washington · P01 · FY2022 · AI
Pathophysiological Actions of Anthrax Virulence Determinants
$1,377,213Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Units for HIV/AIDS Clinical Trials Networks
$1,376,949Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U01 · FY2009 · AI
BSL3 Practices Core
$1,376,860Jay Rappaport · Tulane University Of Louisiana · UC7 · FY2024 · AI
Virus-Like Particle Vaccines for Pandemic Influenza
$1,376,620Ted M Ross · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · AI
Mechanisms of immune-mediated protection and pathogenesis during viral infections
$1,376,440Julie Fox · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Clinical Research Support for the CCR
$1,376,432Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
Clinical Research Support for the CCR
$1,376,369Thomas A Misteli · Division Of Basic Sciences - Nci · ZID · FY2016 · CA
Early Life Vaccination to Prevent HIV acquisition during Adolescence
$1,375,878Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI
Pathogenesis Of Enteric Viral Hepatitis
$1,374,847Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Macque
$1,374,835Francois J Villinger · Emory University · U19 · FY2014 · AI
Acute Hepatitis C Infection in Young Injectors
$1,373,874Kimberly Page · University Of New Mexico Health Scis Ctr · R01 · FY2016 · DA
Core B: GMP Cell and RNA Manufacturing
$1,373,779Bruce L. Levine · University Of Pennsylvania · P01 · FY2017 · CA
Non-Invasive Plant Virus Particle-Based Anthrax Vaccines
$1,373,426Dow Chemical Company · U01 · FY2003 · AI
Influenza Viral Pathogenesis
$1,373,391Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT
$1,373,041Public Health Foundation Enterprises · U01 · FY2003 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of VLP-forming vaccine strategies for HIV-1
$1,373,021Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$1,372,884Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2012 · AI